Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Jul 15, 2019

SELL
$17.59 - $21.1 $9,164 - $10,993
-521 Closed
0 $0
Q1 2019

Apr 02, 2019

BUY
$18.01 - $20.11 $720 - $804
40 Added 8.32%
521 $10,000
Q4 2018

Jan 11, 2019

SELL
$17.44 - $21.53 $784 - $968
-45 Reduced 8.56%
481 $9,000
Q3 2018

Oct 16, 2018

BUY
$19.97 - $21.96 $10,504 - $11,550
526 New
526 $11,000

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.33B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track First Hawaiian Bank Portfolio

Follow First Hawaiian Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Hawaiian Bank, based on Form 13F filings with the SEC.

News

Stay updated on First Hawaiian Bank with notifications on news.